Lenalidomide and Ultram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenalidomide (lenalidomide) and Ultram (tramadol hydrochloride). Common drug interactions include dyspnoea among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Lenalidomide and Ultram. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

On Jul, 26, 2026

47 people who take Lenalidomide and Ultram together, and have interactions are studied.

Lenalidomide and Ultram drug interactions.

What are the common drug interactions of Lenalidomide and Ultram, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Pyrexia (fever)
Cough
Lung infection
Plasma cell myeloma (cancer that begins in plasma cells)
Renal failure (kidney dysfunction)
Haemoglobin decreased
Infection
Rash
Syncope (loss of consciousness with an inability to maintain postural tone)

male:

Anaemia (lack of blood)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Clostridial infection (infectious conditions by clostridium bacteria)
Diffuse large b-cell lymphoma recurrent (recurrent cancer of b cells, a type of white blood cell)
Fluid retention (an abnormal accumulation of fluid in the blood)
Hypotension (abnormally low blood pressure)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Implant site erythema (redness at implant site)
Implant site inflammation
Infection

What are the common drug interactions of Lenalidomide and Ultram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Rash
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Pyrexia (fever)
Syncope (loss of consciousness with an inability to maintain postural tone)
Acute left ventricular failure (heart attack)
Arthralgia (joint pain)
Cardiac failure acute
Contusion (a type of hematoma of tissue in which capillaries)
Gastric disorder (disease of stomach)

60+:

Pyrexia (fever)
Anaemia (lack of blood)
Chronic kidney disease
Clostridial infection (infectious conditions by clostridium bacteria)
Cough
Diffuse large b-cell lymphoma recurrent (recurrent cancer of b cells, a type of white blood cell)
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)
Hypotension (abnormally low blood pressure)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 27 people, 57.45%
Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 19.15%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 17.02%
Nausea (feeling of having an urge to vomit): 7 people, 14.89%
Cough: 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and Ultram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously